Co-monitoring serum anodal trypsinogen, serum amylase, and serum creatinine accurately differentiates rejection from other causes of allograft dysfunction after simultaneous pancreas-kidney transplantation.
Lieberman
J M
JM
Organ Transplant Programs of Northwestern University, USA.
Marks
W H
WH
Stuart
F P
FP
Abecassis
M M
MM
Florence
L S
LS
Kauffman
D
D
D000208:Acute Disease; D000681:Amylases / Q000097:blood* / Q000652:urine; D015415:Biomarkers / Q000097:blood / Q000652:urine; D003404:Creatinine / Q000097:blood*; D003937:Diagnosis, Differential; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008991:Monitoring, Physiologic; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology*; D010195:Pancreatitis / Q000097:blood / Q000175:diagnosis*; D011183:Postoperative Complications / Q000175:diagnosis*; D014184:Transplantation, Homologous; D014362:Trypsinogen / Q000097:blood*
D015415:Biomarkers; D014362:Trypsinogen; D003404:Creatinine; D000681:Amylases